BRITTNEY FISHER: Open Payments
NPI 1265166565 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $454 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $144 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Exact Sciences Corporation | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Intra-Sana Laboratories | 1 | $24 |
| Almatica Pharma LLC | 1 | $23 |
| Alkermes, Inc. | 1 | $23 |
| PROTEGA PHARMACEUTIALS INC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, UZEDY, Cologuard Collection Kit, TRINTELLIX, SPRAVATO, RELTONE 200 MG, LOREEV XR, ARISTADA.
Industry payments across NV — which companies pay providers there.
